Skip to main content
Premium Trial:

Request an Annual Quote

NeuroTherapeutics Pharma Licenses Dotmatics Software for Chemistry Data Management

Premium

Dotmatics said this week that it has licensed its platform to NeuroTherapeutics Pharma, a Chicago Ill.-based biopharmaceutical company.

According to NTP, the company selected Dotmatics' platform to manage its chemistry research and development data.

NTP is using Dotmatic's Browser, Vortex, Gateway, Pinpoint, and Nucleus software tools in its efforts to develop compounds that treat pain, epilepsy, and other nervous system disorders.

Financial details of the licensing agreement were not disclosed.

Other recent licensees of Dotmatics' portfolio include Cancer Therapeutics CRC, Progenra, and Basilea Pharmaceutica (BI 6/8/2012), (BI 5/25/2012), and (BI 5/18/2012).